EUVIMEDEUVIMED entdecken
Leserbrief

Reply to “Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa”

Fabrizio Martora iD, Luca Potestio iD, Teresa Battista iD, Matteo Megna iD

Journal of the European Academy of Dermatology and Venereology · 2024

DOI: 10.1111/jdv.19837 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von Fabrizio Martora und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Adalimumab, Rifampin, Clindamycin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaAdalimumabRifampinClindamycinHumansAnti-Bacterial AgentsDrug Therapy, CombinationTreatment Outcome

Substanzen

AdalimumabRifampinClindamycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

ORCID-Profile: Fabrizio Martora, Luca Potestio, Teresa Battista, Matteo Megna

Zitieren

APA

Martora, F., Potestio, L., Battista, T., & Megna, M. (2024). Reply to “Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa”. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19837

Vancouver

Martora F, Potestio L, Battista T, Megna M. Reply to “Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa”. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19837

BibTeX
@article{Martora2024,
  author = {Martora, Fabrizio and Potestio, Luca and Battista, Teresa and Megna, Matteo},
  title = {Reply to “Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa”},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2024},
  doi = {10.1111/jdv.19837}
}
Kostenlos starten →